6-Bromo-7-nitro-2,3-dihydrobenzo[b][1,4]dioxine, 98%, 10g

2,3,4-Trifluorophenylacetonitrile, 97.0%, 5g

(S)-N-(Tetrahydro-2H-pyran-3-yl)benzamide, 90.0%, 100mg

Methyl 2-methylisonicotinic acid, 95.0%, 250mg

Ethyl 4,5,6,7-tetrahydrothieno[3,2-c]pyridine-3-carboxylate hydrochloride, 95%, 100mg

N-(azetidin-3-yl)pyrazin-2-amine dihydrochloride, 95.0%, 500mg

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-(thiophen-2-yl)acetic acid, 95.0%, 1g

(1r)-1-(3-Bromo-4-fluorophenyl)ethan-1-ol, 97%, 1g

(2-Oxopropyl)carbamic acid tert-butyl ester, 95.0%, 10g

Microliter syringe MICROLITER® series 7000 Point type 3, 5.0 µl, 7105 KH, 1 piece

Ruthenium powder 99.9% 2 g

(R)-3-((tert-Butoxycarbonyl)amino)-4-(3-cyanophenyl)butanoic acid, 97%, 250mg

TERT-BUTYL 3-AMINO-4-CYANO-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXYLATE, 95.0%, 500mg